8UDG image
Entry Detail
PDB ID:
8UDG
EMDB ID:
Title:
S1V2-72 Fab bound to EHA2 from influenza B/Malaysia/2506/2004
Biological Source:
PDB Version:
Deposition Date:
2023-09-28
Release Date:
2023-11-15
Method Details:
Experimental Method:
Resolution:
4.98 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Hemagglutinin
Chain IDs:A, B, C
Chain Length:159
Number of Molecules:3
Biological Source:Influenza B virus (B/Malaysia/2506/2004)
Polymer Type:polypeptide(L)
Description:S1V2-72 heavy chain
Chain IDs:D (auth: H), F (auth: M)
Chain Length:224
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:S1V2-72 light chain
Chain IDs:E (auth: L), G (auth: N)
Chain Length:216
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Protective human antibodies against a conserved epitope in pre- and postfusion influenza hemagglutinin.
Proc.Natl.Acad.Sci.USA 121 e2316964120 e2316964120 (2024)
PMID: 38147556 DOI: 10.1073/pnas.2316964120

Abstact

Phylogenetically and antigenically distinct influenza A and B viruses (IAV and IBV) circulate in human populations, causing widespread morbidity. Antibodies (Abs) that bind epitopes conserved in both IAV and IBV hemagglutinins (HAs) could protect against disease by diverse virus subtypes. Only one reported HA Ab, isolated from a combinatorial display library, protects against both IAV and IBV. Thus, there has been so far no information on the likelihood of finding naturally occurring human Abs that bind HAs of diverse IAV subtypes and IBV lineages. We have now recovered from several unrelated human donors five clonal Abs that bind a conserved epitope preferentially exposed in the postfusion conformation of IAV and IVB HA2. These Abs lack neutralizing activity in vitro but in mice provide strong, IgG subtype-dependent protection against lethal IAV and IBV infections. Strategies to elicit similar Abs routinely might contribute to more effective influenza vaccines.

Legend

Protein

Chemical

Disease

Primary Citation of related structures